EUVIMEDEUVIMED entdecken
Crossref

Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma

Qiaoying Tian, Lin Jiang, Dongjun Dai, Lihong Liu, Xiaomeng Shi, Yinglu Guo, Dang Wu, Jia Yang, Jing Xu, Zhuoying Cai, Zhimin Ye, Yun Xi iD und 7 weitere

Journal of Clinical Oncology · 20.05.2024 · 42 (15) · 1754-1765

DOI: 10.1200/jco.23.01106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.05.2024. Verfasst von Qiaoying Tian und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molec…. Hauptthemen laut MEDLINE: Tongue Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To identify subgroups of patients with early-stage (pT1-2N0M0) oral tongue squamous cell carcinoma (OTSCC) who may benefit from postoperative radiotherapy (PORT). PATIENTS AND METHODS This retrospective cohort study included 528 patients diagnosed between October 2009 and December 2021. Clinicopathological characteristics and treatments with or without PORT were analyzed for their impact on outcomes. RESULTS Among 528 patients who underwent radical surgery (median age, 62 years [IQR, 52-69]), 145 (27.5%) also underwent PORT. Multivariate analyses revealed that PORT was associated with improved survival outcomes, whereas moderate-to-poor differentiation, perineural infiltration (PNI), lymphovascular invasion (LVI), and increasing depth of invasion (DOI) were associated with poorer survival outcomes. For patients with moderate-to-poor differentiation, the surgery + PORT group showed improved outcomes compared with the surgery-alone group. After propensity score matching, the results were as follows: overall survival (OS), 97% versus 69%, P = .003; disease-free survival (DFS), 88% versus 50%, P = .001. After excluding cases with PNI/LVI, the differences persisted: OS, 97% versus 82%, P = .040; DFS, 87% versus 64%, P = .012. Similar survival benefits were observed in 104 patients with PNI and/or LVI (OS, 81% v 58%; P = .022; DFS, 76% v 47%; P = .002). In subgroups with DOI >5 mm or close margins, PORT contributed to improved DFS (80% v 64%; P = .006; 92% v 66%; P = .049) but did not significantly affect OS. CONCLUSION Patients with moderately-to-poorly differentiated pT1-2N0M0 OTSCC benefited from PORT. Our study provided evidence that patients with PNI and/or LVI who underwent PORT had improved survival. PORT also offered DFS benefit among patients with DOI >5 mm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tongue NeoplasmsNeoplasm StagingHumansMiddle AgedMaleFemaleAgedRetrospective StudiesPrognosisRadiotherapy, AdjuvantSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell

Autor:innen und Institutionen

  • Department of Radiation Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences), The Second Affiliated Hospital, Zhe…
  • Zhejiang Provincial Clinical Research Center for Cancer, Hangzhou, China.
  • Cancer Center of Zhejiang University, Hangzhou, China.
  • Department of Surgical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province, Hangzhou, China.
  • Department of Reproductive Endocrinology, The Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Yun Xi, Zengguang Zheng, Qichun Wei

Zitieren

APA

Tian, Q., Jiang, L., Dai, D., Liu, L., Shi, X., Guo, Y., Wu, D., Yang, J., Xu, J., Cai, Z., Ye, Z., Xi, Y., Zheng, Z., Li, H., Shui, Y., Liu, Y., Shang, J., Wei, S., & Wei, Q. (2024). Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma. Journal of Clinical Oncology, 42(15), 1754-1765. https://doi.org/10.1200/jco.23.01106

Vancouver

Tian Q, Jiang L, Dai D, Liu L, Shi X, Guo Y, et al. Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma. Journal of Clinical Oncology. 2024;42(15):1754-1765. doi:10.1200/jco.23.01106

BibTeX
@article{Tian2024,
  author = {Tian, Qiaoying and Jiang, Lin and Dai, Dongjun and Liu, Lihong and Shi, Xiaomeng and Guo, Yinglu and Wu, Dang and Yang, Jia and Xu, Jing and Cai, Zhuoying and Ye, Zhimin and Xi, Yun and Zheng, Zengguang and Li, Huimin and Shui, Yongjie and Liu, Yanming and Shang, Jinbiao and Wei, Shumei and Wei, Qichun},
  title = {Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {15},
  pages = {1754--1765},
  doi = {10.1200/jco.23.01106}
}
Kostenlos starten →